For citations:
Teillac P., Heyns C.F., Kaisary A.V., Bouchot O., Blumberg J. PHARMACODYNAMIC EQUIVALENCE OF USING 3-MONTH AND 28-DAY SUSTAINED-RELEASE DECAPEPTYL DEPOT FORMULATIONS IN PATIENTS WITH ADVANCED PROSTATE CANCER. Cancer Urology. 2009;5(1):68-71. (In Russ.) https://doi.org/10.17650/1726-9776-2009-5-1-68-71